Drugs Made In America Acquisition II Corp.(DMII)— Stock Profile, AI Score & Financials

Financials · Nasdaq · AI-powered stock analysis, 32-signal quality score, SEC EDGAR financials, and institutional holdings. Updated 2026-06-30.

Drugs Made In America Acquisition II Corp. (DMII) stock profile, AI quality score, and SEC EDGAR financial data, a Financials sector company. DMII is not currently included in 13F Pro's AI-ranked quality universe — this company passes all size and coverage filters but hasn't been included in the latest quarterly ranking run. rankings refresh on jan 1, apr 1, jul 1, oct 1. Top institutional holders of DMII by reported 13-F value include Karpus Management, MMCAP International SPC, Magnetar Financial, based on the most recent SEC filings. DMII trades on the Nasdaq exchange and files with the SEC under CIK 2040475. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate DMII daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Drugs Made In America Acquisition II Corp. directly from SEC EDGAR.